High Mobility Group Box 1 and Interleukin 6 at intensive care unit admission as biomarkers in critically ill COVID-19 patients
Exuberant inflammation manifesting as a “cytokine storm” has been suggested as a central feature in the pathogenesis of severe coronavirus disease 2019 (COVID-19). This study investigated two prognostic biomarkers, the high mobility group box 1 (HMGB1) and interleukin-6 (IL-6), in patients with seve...
Main Authors: | Sivakorn, C, Dechsanga, J, Jamjumrus, L, Boonnak, K, Schultz, MJ, Dorndorp, AM, Phumratanaprapin, W, Ratanarat, R, Naorungroj, T, Wattanawinitchai, P, Siripoon, T, Duangdee, C, Techarang, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Tropical Medicine and Hygiene
2021
|
Similar Items
-
Critical care management of patients with COVID-19: early experience in Thailand
by: Ratanarat, R, et al.
Published: (2020) -
How to monitor cardiovascular function in critical illness in resource-limited settings
by: Sivakorn, C, et al.
Published: (2021) -
Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.
by: Sivakorn, C, et al.
Published: (2021) -
Challenges and opportunities for lung ultrasound in novel Coronavirus disease (COVID-19)
by: Schultz, MJ, et al.
Published: (2020) -
The prognostic capacity of the radiographic assessment for lung edema score in patients with COVID-19 acute respiratory distress syndrome—an international multicenter observational study
by: Valk, CMA, et al.
Published: (2021)